Slaughter and May is advising Mediclinic International plc on Ramsay Health Care Limited's Recommended Cash Offer for Spire Healthcare Group plc

Slaughter and May is advising Mediclinic International plc (“Mediclinic”) in relation to the recommended cash offer made by Ramsay Health Care Limited for the entire issued and to be issued ordinary share capital of Spire Healthcare Group plc (“Spire”). Mediclinic holds a 29.9 per cent. shareholding in Spire.

Under the terms of the offer, Spire shareholders will receive 240 pence per Spire share. The transaction was announced on 26 May 2021 and is subject to customary conditions, including the approval of Spire shareholders.

Slaughter and May previously advised Mediclinic on its original acquisition of the shareholding in Spire in 2015.